BIOSECURE Act落地：规则与中国生物医药企业的应对
尽早完成自查与预案化建设，通常更有利于把不确定性压缩为可管理的合规成本。
Time：
2025-12-19 21:08
Author：
小爱同学
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务